BlackRock
SCMP

BlackRock’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

BlackRock’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,074,950
Closed -$73.1M – 5094
2017
Q4 		$73.1M Buy
4,074,950
+135,012
+3% +$1.66M ﹤0.01% 2055
2017
Q3 		$46.5M Buy
3,939,938
+144,487
+4% +$1.62M ﹤0.01% 2340
2017
Q2 		$39.9M Buy
3,795,451
+228,677
+6% +$2.33M ﹤0.01% 2392
2017
Q1 		$39.2M Buy
3,566,774
+3,562,748
+88,493% +$41.4M ﹤0.01% 2375
2016
Q4 		$55K Sell
4,026
-16,187
-80% -$226K ﹤0.01% 2890
2016
Q3 		$249K Sell
20,213
-1,299
-6% -$15.3K ﹤0.01% 2042
2016
Q2 		$236K Buy
21,512
+20,065
+1,387% +$225K ﹤0.01% 2013
2016
Q1 		$15K Buy
1,447
+952
+192% +$12K ﹤0.01% 2997
2015
Q4 		$9K Hold
495
– – ﹤0.01% 2958
2015
Q3 		$10K Hold
495
– – ﹤0.01% 2745
2015
Q2 		$8K Buy
+495
New +$8.58K ﹤0.01% 2950

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

BlackRock's SCMP Position: Q1 2018 in Review

BlackRock sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 4,074,950 shares — an estimated $73.1M sold.

BlackRock first reported a position in SCMP in Q2 2015 and held it in 11 quarters. The position peaked at $73.1M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • BlackRock reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • BlackRock sold 4,074,950 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $73.1M.
  • BlackRock first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 11 quarters.
  • BlackRock's Sucampo Pharmaceuticals, Inc. position peaked at $73.1M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on BlackRock's 13F filing for Q1 2018, filed 9 May 2018.